Robert Z. Maigetter

1.3k total citations · 1 hit paper
26 papers, 977 citations indexed

About

Robert Z. Maigetter is a scholar working on Molecular Biology, Epidemiology and Biotechnology. According to data from OpenAlex, Robert Z. Maigetter has authored 26 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Biotechnology. Recurrent topics in Robert Z. Maigetter's work include Transgenic Plants and Applications (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Protein purification and stability (4 papers). Robert Z. Maigetter is often cited by papers focused on Transgenic Plants and Applications (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Protein purification and stability (4 papers). Robert Z. Maigetter collaborates with scholars based in United States, Japan and Canada. Robert Z. Maigetter's co-authors include W. J. McAleer, D. Eugene Wampler, William J. Miller, Eugene B. Buynak, M. R. Hilleman, F. James Bailey, James D. Fenters, Donald E. Gardner, R. Ehrlich and C I Ragan and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

Robert Z. Maigetter

26 papers receiving 906 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human hepatitis B vaccine from recombinant yeast

1984 529 citations W. J. McAleer, Eugene B. Buynak et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Z. Maigetter United States	13	397	348	201	185	135	26	977
Heinrich G. Köchel Germany	17	478 1.2×	565 1.6×	125 0.6×	235 1.3×	80 0.6×	23	1.1k
Robert H. Schloemer United States	15	293 0.7×	503 1.4×	145 0.7×	138 0.7×	165 1.2×	27	879
John C. Petricciani United States	15	308 0.8×	138 0.4×	134 0.7×	213 1.2×	202 1.5×	63	833
Brian J. Ledwith United States	17	864 2.2×	169 0.5×	385 1.9×	264 1.4×	252 1.9×	30	1.4k
James E. Estep United States	19	688 1.7×	202 0.6×	146 0.7×	449 2.4×	325 2.4×	22	1.2k
Thierry Huet France	13	423 1.1×	296 0.9×	203 1.0×	482 2.6×	120 0.9×	18	1.2k
Sujata Manam United States	16	809 2.0×	142 0.4×	371 1.8×	245 1.3×	249 1.8×	23	1.3k
Peter T. Loudon United Kingdom	17	355 0.9×	242 0.7×	271 1.3×	245 1.3×	80 0.6×	28	1.1k
Biswendu B. Goswami United States	15	201 0.5×	180 0.5×	90 0.4×	250 1.4×	84 0.6×	32	603
Monica Sala France	17	279 0.7×	184 0.5×	219 1.1×	368 2.0×	53 0.4×	39	894

Countries citing papers authored by Robert Z. Maigetter

Since Specialization

Citations

This map shows the geographic impact of Robert Z. Maigetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Z. Maigetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Z. Maigetter more than expected).

Fields of papers citing papers by Robert Z. Maigetter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Z. Maigetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Z. Maigetter. The network helps show where Robert Z. Maigetter may publish in the future.

Co-authorship network of co-authors of Robert Z. Maigetter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Z. Maigetter. A scholar is included among the top collaborators of Robert Z. Maigetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Z. Maigetter. Robert Z. Maigetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moss, Ronald B., Wieslawa Giermakowska, Mark R. Wallace, et al.. (2001). Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen. Clinical & Experimental Immunology. 124(2). 248–254. 2 indexed citations

Richieri, Steven P., Richard M. Bartholomew, Roland C. Aloia, et al.. (1998). Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine. 16(2-3). 119–129. 41 indexed citations

Kniskern, Peter J., Arpi Hagopian, Loren D. Schultz, et al.. (1994). Characterization and evaluation of a recombinant hepatitis B vaccine expressed in yeast defective for N-linked hyperglycosylation. Vaccine. 12(11). 1021–1025. 24 indexed citations

George, H, Mary Ellen Dahlgren, Wayne K. Herber, et al.. (1992). Physiological effects of TGF_α‐PE40 expression in recombinant Escherichia coli JM109. Biotechnology and Bioengineering. 40(3). 437–445. 34 indexed citations

McAllister, George, Paul J. Whiting, Michael R. Knowles, et al.. (1992). cDNA cloning of human and rat brain myo-inositol monophosphatase. Expression and characterization of the human recombinant enzyme. Biochemical Journal. 284(3). 749–754. 91 indexed citations

Hoff, Daniel D. Von, Martha H. Marshall, David Heimbrook, et al.. (1992). Activity of a recombinant transforming growth factor-α-Pseudomonas exotoxin hybrid protein against primary human tumor colony-forming units. Investigational New Drugs. 10(1). 17–22. 7 indexed citations

Patrick, Denis R., Deborah Defeo-Jones, Robert Z. Maigetter, et al.. (1992). Characterization of functional HPV-16 E7 protein produced in Escherichia coli.. Journal of Biological Chemistry. 267(10). 6910–6915. 24 indexed citations

Ellis, Ronald, et al.. (1991). Production of hepatitis B surface antigen (PreS2 + S) by high-cell density cultivations of a recombinant yeast. Journal of Biotechnology. 21(1-2). 109–125. 17 indexed citations

Herber, Wayne K., et al.. (1991). Production of cytotoxic proteins in Escherichia coli: a fermentation process for producing enzymatically active HIV-1 protease. Applied Microbiology and Biotechnology. 36(2). 149–152. 6 indexed citations

10.

Hofmann, Kathryn J., Paul M. Keller, Mark A. Polokoff, et al.. (1990). Regulated production of recombinant echistatin by yeast. Biotechnology Letters. 12(12). 879–884. 5 indexed citations

11.

Bailey, F. James, et al.. (1990). Harvesting recombinant microbial cells using crossflow filtration. Enzyme and Microbial Technology. 12(9). 647–652. 8 indexed citations

12.

Kniskern, Peter J., Arpi Hagopian, Diana Montgomery, et al.. (1989). The Application of Molecular Biology to the Development of Novel Vaccines. PubMed. 251. 83–98. 7 indexed citations

13.

Tekamp-Olson, Patricia, et al.. (1989). Galactose-regulated expression of hepatitis B surface antigen by a recombinant yeast. Biotechnology Letters. 11(5). 301–306. 5 indexed citations

14.

Emini, Emilio A., Melvin Silberklang, Loren D. Schultz, et al.. (1988). Antigenic analysis of the epstein-barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: Implications for the development of a subunit vaccine. Virology. 166(2). 387–393. 31 indexed citations

15.

Bailey, F. James, et al.. (1987). High-cell-density fermentation studies of a recombinantE. coli that expresses atrial natriuretic factor. Journal of Industrial Microbiology & Biotechnology. 2(1). 47–52. 12 indexed citations

16.

McAleer, W. J., Eugene B. Buynak, Robert Z. Maigetter, et al.. (1984). Human hepatitis B vaccine from recombinant yeast. Nature. 307(5947). 178–180. 529 indexed citations breakdown →

17.

Limjuco, G, et al.. (1978). Studies on the Chemical Composition of Lipopolysaccharide from Neisseria meningitidis Group B. Journal of General Microbiology. 104(2). 187–191. 7 indexed citations

18.

Maigetter, Robert Z., R. Ehrlich, James D. Fenters, & Donald E. Gardner. (1976). Potentiating effects of manganese dioxide on experimental respiratory infections. Environmental Research. 11(3). 386–391. 26 indexed citations

19.

Maigetter, Robert Z. & Robert M. Pfister. (1975). A mixed bacterial population in a continuous culture with and without kaolinite. Canadian Journal of Microbiology. 21(2). 173–180. 5 indexed citations

20.

Ehrlich, R., et al.. (1975). Immunologic response in vaccinated mice during long-term exposure to nitrogen dioxide. Environmental Research. 10(2). 217–223. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact